Our mission at Causaly is to redefine the boundaries of human discovery by harnessing transformative AI technologies. Founded in 2018, Causaly’s unique AI platform is a powerful catalyst for the modern Life Science research organization, reshaping how data is found, analyzed and applied in critical decision-making processes in drug discovery and development. Supporting a broad range of complex knowledge workflows, our platform accelerates the journey from bench research and laboratory insights to the launch of life-changing therapies.
Looking for a particular Causaly employee's phone or email?
The Causaly annual revenue was $27.3 million in 2026.
Yiannis Kiachopoulos is the Co-founder, CEO of Causaly.
115 people are employed at Causaly.
The NAICS codes for Causaly are [51121, 511, 5112, 511210, 51, 518].
The SIC codes for Causaly are [737, 73].